Clinical Study Results
How many participants had serious adverse events?
There were 2.4% of participants who got MEDI4920 who had serious adverse events
during the study. This was 1 out of 42 participants. This serious adverse event was
swelling in the brain. The study doctors did not think this serious adverse event was
related to the study treatment.
None of the participants who got the placebo had serious adverse events during the
study.
None of the participants died due to serious adverse events during the study.
The websites listed at the end of this summary may have other information about adverse
events that happened during this study.
How many participants had adverse events?
The table below shows how many participants had adverse events during the study.
Adverse events during the study
75 mg 500 mg 1,000 mg 1,500 mg
MEDI4920 MEDI4920 MEDI4920 MEDI4920 Placebo
(out of 8 (out of 10 (out of 12 (out of 12 (out of 15
participants) participants) participants) participants) participants)
How many
participants had
37.5% (3) 70.0% (7) 50.0% (6) 83.3% (10) 86.7% (13)
adverse events
during the study?
How many
participants had
serious adverse 0.0% (0) 0.0% (0) 0.0% (0) 8.3% (1) 0.0% (0)
events during the
study?
How many
participants
stopped treatment 12.5% (1) 0.0% (0) 0.0% (0) 8.3% (1) 0.0% (0)
because of adverse
events?
4